Description
Dacarbazine is an alkylator that attaches alkyl groups to purine bases on DNA; it exhibits anticancer chemotherapeutic activity. Dacarbazine is clinically used to treat various forms of cancer.
Dacarbazine is an alkylator that attaches alkyl groups to purine bases on DNA; it exhibits anticancer chemotherapeutic activity. Dacarbazine is clinically used to treat various forms of cancer.
Cas No. | 4342-03-4 |
---|---|
Purity | ≥98% |
Formula | C6H10N6O |
Formula Wt. | 182.18 |
Chemical Name | 5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4- carboxamide |
IUPAC Name | (5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide |
Synonym | Dacatic; DTIC-Dome; Deticene |
Melting Point | 205°C |
Solubility | Slightly soluble in water and alcohol. |
Appearance | Light pink powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | D0011 MSDS PDF |
---|---|
Info Sheet | D0011 Info Sheet PDF |
Gallamini A, Di Raimondo F, La Nasa G, et al. Standard therapies versus novel therapies in Hodgkin lymphoma. Immunol Lett. 2013 Sep-Oct;155(1-2):56-9. PMID: 24140162.
Koprowska K, Czyż M. Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities. Postepy Hig Med Dosw (Online). 2011 Nov 23;65:734-51. PMID: 22173438.